Article
Response predictors to treatment with pegylated interferon in chronic hepatitis B.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases - 1 Jan 2000
Ferreira Paulo Roberto Abrão, Tenore Simone de Barros
Abstract excerpt
The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
